Synapse - Works

Results (4760)

Exposure-response of olaratumab for survival outcomes and safety when combined with doxorubicin in soft tissue sarcoma (STS) patients

Meeting Abstract

Jones, R.; Mo, G.; Baldwin, J. R.; Nichols, R. D.; Ilaria, R. L.; Conti, I.; Cronier, D. M.; Tap, W. D.
Annals of Oncology (2016)

Fulltext@MSK | Save

Tumor mutation load assessed by FoundationOne (FM1) is associated with improved efficacy of atezolizumab (atezo) in patients with advanced NSCLC

Meeting Abstract

Kowanetz, M.; Zou, W.; Shames, D. S.; Cummings, C.; Rizvi, N.; Spira, A. I.; Frampton, G. M.; Leveque, V.; Flynn, S.; Mocci, S.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Clinical activity of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC) and a BRCA mutation (BRCAmut): Analysis of pooled data from Study 10 (parts 1, 2a, and 3) and ARIEL2 (parts 1 and 2)

Meeting Abstract

Kristeleit, R. S.; Shapira-Frommer, R.; Oaknin, A.; Balmana, J.; Ray-Coquard, I. L.; Domchek, S.; Tinker, A. V.; Castro, C. M.; Welch, S.; Poveda, A. M.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase 1 study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer

Meeting Abstract

Laetsch, T. W.; Nagasubramanian, R.; Dubois, S. G.; Mascarenhas, L.; Hawkins, D.; Shukla, N.; Turpin, B.; Smith, S.; Reynolds, M.; Cruickshank, S.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study

Meeting Abstract

Loriot, Y.; Rosenberg, J. E.; Powles, T. B.; Necchi, A.; Hussain, S.; Morales, R.; Retz, M.; Niegisch, G.; Duran, I.; Theodore, C.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)(+) metastatic breast cancer (MBC): Pharmacokinetics (PK)

Meeting Abstract

Gucalp, A.; Corben, A.; Patil, S.; Boyle, L. A.; Hudis, C.; Traina, T. A.
Annals of Oncology (2016)

Fulltext@MSK | Save

Updated results from a phase I study of nivolumab (nivo) in combination with ipilimumab (ipi) in metastatic renal cell carcinoma (mRCC): The CheckMate 016 study

Meeting Abstract

Hammers, H.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D.; Lewis, L.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Evaluation of the novel "trial within a trial" design of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC)

Meeting Abstract

Hessel, C.; Mangeshkar, M.; Motzer, R. J.; Escudier, B.; Powles, T. B.; Schwab, G.; Choueiri, T. K.
Annals of Oncology (2016)

Fulltext@MSK | Save

Insomnia prevalence in an oncology patient population: An Irish tertiary referral centre experience

Meeting Abstract

Harrold, E. C.; Idris, A. F.; Keegan, N. M.; Corrigan, L.; Teo, M. Y.; Lim, S. T.; Duff, E.; Donnell, M. O.; Kennedy, J.; O'Donnell, D.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy

Meeting Abstract

Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save